Cargando…

Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme

In this study, we have compared four (68)Ga-labeled peptides (three Arg-Gly-Asp (RGD) peptides and substance-P) with two (18)F-tracers clinically approved for tumor imaging. We have studied in vitro and in vivo characteristics of selected radiolabeled tracers in a glioblastoma multiforme tumor model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novy, Zbynek, Stepankova, Jana, Hola, Michaela, Flasarova, Dominika, Popper, Miroslav, Petrik, Milos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651196/ https://www.ncbi.nlm.nih.gov/pubmed/31288488 http://dx.doi.org/10.3390/molecules24132496

Ejemplares similares

[(68)Ga]Ga-Ornibactin for Burkholderia cepacia complex Infection Imaging Using Positron Emission Tomography
por: Bendova, Katerina, et al.
Publicado: (2023)

Head-To-Head Comparison of Biological Behavior of Biocompatible Polymers Poly(Ethylene Oxide), Poly(2-Ethyl-2-Oxazoline) and Poly[N-(2-Hydroxypropyl)Methacrylamide] as Coating Materials for Hydroxyapatite Nanoparticles in Animal Solid Tumor Model
por: Novy, Zbynek, et al.
Publicado: (2020)

Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study
por: Reissig, Falco, et al.
Publicado: (2021)

(68)Ga-labelled desferrioxamine-B for bacterial infection imaging
por: Petrik, Milos, et al.
Publicado: (2020)

[(68)Ga]Ga-DFO-c(RGDyK): Synthesis and Evaluation of Its Potential for Tumor Imaging in Mice
por: Krajcovicova, Sona, et al.
Publicado: (2021)

Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas
por: Bertagna, Francesco, et al.
Publicado: (2020)

Evaluation of (68)Ga-Radiolabeled Peptides for HER2 PET Imaging
por: Ducharme, Maxwell, et al.
Publicado: (2022)

Radiolabeling of Nanoparticles and Polymers for PET Imaging
por: Stockhofe, Katharina, et al.
Publicado: (2014)

State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET
por: Chomet, Marion, et al.
Publicado: (2021)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Radiolabeled PET/MRI Nanoparticles for Tumor Imaging
por: Forte, Ernesto, et al.
Publicado: (2019)

Radiolabelling of Extracellular Vesicles for PET and SPECT imaging
por: Khan, Azalea A., et al.
Publicado: (2021)

Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study
por: Ferrari, Cristina, et al.
Publicado: (2015)

Preclinical evaluation of (68)Ga-radiolabeled trimeric affibody for PDGFRβ-targeting PET imaging of hepatocellular carcinoma
por: Cai, Huawei, et al.
Publicado: (2023)

In Vitro and In Vivo Comparison of Selected Ga-68 and Zr-89 Labelled Siderophores
por: Petrik, Milos, et al.
Publicado: (2015)

Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin α(v)β(3)
por: Chen, Haojun, et al.
Publicado: (2016)

Evaluation of a Radiolabeled Macrocyclic Peptide as Potential PET Imaging Probe for PD−L1
por: Jouini, Nedra, et al.
Publicado: (2022)

Validation of Freshly Isolated Rat Renal Cells as a Tool for Preclinical Assessment of Radiolabeled Receptor-Specific Peptide Uptake in the Kidney
por: Barta, Pavel, et al.
Publicado: (2023)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
por: van Dongen, Guus A. M. S., et al.
Publicado: (2012)

Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts
por: Liu, Xujie, et al.
Publicado: (2016)

Radiolabeled Cationic Peptides for Targeted Imaging of Infection
por: Aweda, Tolulope A., et al.
Publicado: (2019)

Radiolabelled peptides for oncological diagnosis
por: Laverman, Peter, et al.
Publicado: (2012)

Radiolabeled Peptides and Antibodies in Medicine
por: Kręcisz, Paweł, et al.
Publicado: (2020)

Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
por: Joosten, Lieke, et al.
Publicado: (2017)

Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice
por: Lo, Wei-Lin, et al.
Publicado: (2021)

Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging
por: Sardana, Malvika, et al.
Publicado: (2022)

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
por: Kirchner, Maximilian A., et al.
Publicado: (2021)

Advanced Magnetic Resonance Imaging of Glioblastoma Multiforme
por: Ravikanth, Reddy
Publicado: (2017)

The Radiolabeling of [161Tb]-PSMA-617 by a Novel Radiolabeling Method and Preclinical Evaluation by In Vitro/In Vivo Methods
por: UYGUR, EMRE, et al.
Publicado: (2023)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_guio43fs87tqaeno8kohesc6v8